Krystal Morales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Krystal Morales has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Andrew G. Shuman
Department of Otolaryngology-Head & Neck Surgery and the Center for Bioethics and Social Sciences in Medicine, University of Michigan Medical School, Ann Arbor, MI, United States of America
24 shared publications - Andrew J. Rosko
University of Michigan Department of Otolaryngology-Head and Neck Surgery, 1540 E. Hospital Drive, Ann Arbor, MI 48109, USA
24 shared publications - Avraham Eisbruch
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
24 shared publications - Benjamin Rosen
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan
24 shared publications - Caitlin A. Schonewolf
Natera, Inc. Oncology Austin, TX 78753
24 shared publications - Chaz L. Stucken
Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan
24 shared publications
Latest Publications
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Odds ratios (OR) and p values for multi-variable models for acute and late toxicity outcomes including covariates of p16+ OPSCC vs LAHNSCC, primary tumor volume (GTVp) and RT boost volume treated.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Odds ratios (OR) and p values for multi-variable models for acute and late toxicity outcomes including covariates of p16+ OPSCC vs LAHNSCC, primary tumor volume (GTVp) and RT boost volume treated.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
KM curves of average patient p16+ and p16- LRF outcomes. Plot for estimated incidence of loco-regional failure (LRF) with the median boost volume (6.9cc) and GTV primary (54.8cc) for: p16+ OPSCC (left panel) and LAHNSCC (right panel).
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
KM curves of average patient p16+ and p16- LRF outcomes. Plot for estimated incidence of loco-regional failure (LRF) with the median boost volume (6.9cc) and GTV primary (54.8cc) for: p16+ OPSCC (left panel) and LAHNSCC (right panel).
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
LAHNSCC patients by treatment site and stage
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
LAHNSCC patients by treatment site and stage
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Multi-variable model for loco-regional control in randomized patients including covariates of chemotherapy regimen and smoking history
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Multi-variable model for loco-regional control in randomized patients including covariates of chemotherapy regimen and smoking history
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Patterns of Failure in all patients enrolled to clinical trial
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Patterns of Failure in all patients enrolled to clinical trial
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Linear mixed model results for arm*time interaction EORTC QLQ30/HN35 PRO subscales.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Linear mixed model results for arm*time interaction EORTC QLQ30/HN35 PRO subscales.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Characteristics of patients in non-randomized cohort who had <1cc of overlapped LBV and LADC MRI boostable tumor subvolume.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Characteristics of patients in non-randomized cohort who had <1cc of overlapped LBV and LADC MRI boostable tumor subvolume.
- Open Access
- 1 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Odds ratios (OR) and p values for multi-variable models for acute and late toxicity outcomes including covariates of p16+ OPSCC vs LAHNSCC, primary tumor volume (GTVp) and RT boost volume treated.
- 1 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Odds ratios (OR) and p values for multi-variable models for acute and late toxicity outcomes including covariates of p16+ OPSCC vs LAHNSCC, primary tumor volume (GTVp) and RT boost volume treated.
- Open Access
- 1 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
LAHNSCC patients by treatment site and stage
- 1 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
LAHNSCC patients by treatment site and stage
- Open Access
- 1 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Odds ratios (OR) and p values for multi-variable models for acute and late toxicity outcomes including covariates of p16+ OPSCC vs LAHNSCC, primary tumor volume (GTVp) and RT boost volume treated.
- 1 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Odds ratios (OR) and p values for multi-variable models for acute and late toxicity outcomes including covariates of p16+ OPSCC vs LAHNSCC, primary tumor volume (GTVp) and RT boost volume treated.